Results 201 to 210 of about 86,651 (264)

Pharmacokinetic modelling as a tool to assess TB treatment adherence: application to the REMEMBER study. [PDF]

IJTLD Open
Abdelgawad N, Chirehwa M, McIlleron H, Kanyama C, Mwelase N, Naidoo A, Kumwenda J, Nyirenda M, Samaneka WP, Lama JR, Mohapi L, Mave V, Veloso VG, Valencia J, Gupta A, Hosseinipour MC, Scarsi K, Denti P.   +17 more
europepmc   +1 more source

Evaluation of T-NGS, Xpert Ultra, and Line Probe Assay on Clinical Samples for the Diagnosis of Drug-Resistant Pulmonary Tuberculosis in Rio de Janeiro. [PDF]

Rev Soc Bras Med Trop
Bhering M, Ribeiro EP, Silveira AK, Lalucha C, Ribeiro EO, Igreja T, Pôrto LC, Secco D, Silva PEAD, Viveiros M, Oliveira M, Kritski A.   +11 more
europepmc   +1 more source

Tuberculosis after TB Preventive Therapy in Persons Living with HIV Recently Initiating Antiretroviral Therapy, Mozambique. [PDF]

Emerg Infect Dis
Templin L, Varajidas Y, Respeito D, Zindoga P, Weiss D, Nguimfack A, Filipe E, Mahumane A, de Deus MIT, Mizela J, Chilundo S, Simoes B, Couto A, Pathmanathan I, Dirlikov E, José B.   +15 more
europepmc   +1 more source

Evaluation of neurotoxicity of drugs from morphological and electrophysiological endpoints using human iPSC-derived neural cell models. [PDF]

Front Cell Infect Microbiol
Qu Z, Li S, Qiu J, Huo G, Liu Y, Zhang D, Yang Y, Geng X, Lin Z.   +8 more
europepmc   +1 more source

A Case of Evolving Hepatotoxicity Following Systemic Drug Reaction to Isoniazid-Rifapentine (3HP). [PDF]

Case Reports Hepatol
Vizgan N, Martinez-Kratz J, LaBudde C, Gordon F.   +3 more
europepmc   +1 more source

Extensive Endemic Transmission of Multidrug-Resistant <i>Mycobacterium tuberculosis</i> in Bhutan: A Retrospective Genomic-Epidemiological Study. [PDF]

Open Forum Infect Dis
Dorji T, Tshering K, Adhikari L, Jamtsho T, Bhujel P, Lhaden P, Wangchuk S, Wirth W, Horan K, Denholm JT, Sherry NL, Sait M, Stinear TP, Howden BP, Andersson P.   +14 more
europepmc   +1 more source

Isolated ovarian tuberculosis in a hemodialysis patient: An incidental pre-transplant discovery with diagnostic and management implications. [PDF]

IDCases
Hormatallah A, Asakak I, Slama L, Aberkane M, Harmouche M, Chatbi Z, Bellajdel I, Taheri H, Saadi H, Mimouni A.   +9 more
europepmc   +1 more source

Prevalence and resistance spectrum of <i>ahpC</i> mutations in isoniazid-resistant <i>Mycobacterium tuberculosis</i> isolates. [PDF]

Microbiol Spectr
Wu X, Zheng H, Chen Y, Zhao B, Li F, Xia H, Xiao J, Qi H, Jiao W, Mi K, Ou X, Zhao Y, Sun L.   +12 more
europepmc   +1 more source

Hepatotoxicity Risk of Isoniazid in Patients with Autoimmune Rheumatic Diseases and Prior Liver Injury Due to Disease-Modifying Antirheumatic Drugs: A Single-Center Experience and Literature Review. [PDF]

J Clin Med
Osorio-Chávez JS, Portilla González V, Ferraz-Amaro I, Castañeda S, Cifrián Martínez JM, Blanco Alonso R.   +5 more
europepmc   +1 more source

Antimicrobial therapy combined with C-C chemokine receptor type 2 modulation dampens mycobacteria-aggravated monocyte activation and atherosclerosis. [PDF]

Front Cardiovasc Med
Egoavil-Espejo R, Haller A, Feria MG, Jain SK, Singh M, Zhang B, Qualls JE, Hui DY, Huaman MA.   +8 more
europepmc   +1 more source